Short-Term Neurodevelopmental Outcome in Term Neonates Treated with Phenobarbital versus Levetiracetam: A Single-Center Experience
Background. Phenobarbital (PB) has been traditionally used as the first-line treatment for neonatal seizures. More recently, levetiracetam (LEV) has been increasingly used as a promising newer antiepileptic medication for treatment of seizures in neonates. Objectives. The aim of our study was to com...
Saved in:
Main Authors: | Raffaele Falsaperla, Laura Mauceri, Piero Pavone, Massimo Barbagallo, Giovanna Vitaliti, Martino Ruggieri, Francesco Pisani, Giovanni Corsello |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Behavioural Neurology |
Online Access: | http://dx.doi.org/10.1155/2019/3683548 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid Spontaneous Resolution of Fibromatosis Colli in a 3-Week-Old Girl
by: Paolo Adamoli, et al.
Published: (2014-01-01) -
Acute Glomerulonephritis in a Child with Chlamydia pneumoniae Infection: A Case Report
by: Giovanna Vitaliti, et al.
Published: (2013-01-01) -
Comparison of neurodevelopmental outcome in late-preterm and term neonates at 9-month corrected age
by: Sarfaraz Nisar, et al.
Published: (2025-01-01) -
Levetiracetam versus Phenobarbitone in Neonatal Seizures - An Open label Randomized Controlled Trial
by: Nikhil D Kulkarni, et al.
Published: (2025-01-01) -
Levetiracetam-Induced Parkinsonism: A Short Case Series
by: Thomas Mathew, et al.
Published: (2024-12-01)